Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 18;3(1):100490.
doi: 10.1016/j.xcrm.2021.100490.

Potential role of neurofilament in COVID-19 and preeclampsia

Affiliations

Potential role of neurofilament in COVID-19 and preeclampsia

Athina Samara et al. Cell Rep Med. .

Abstract

Neurofilament light (NFL) is a promising circulating biomarker in preeclampsia and COVID-19, even without evident neurological complications. Several pathways might contribute to the elevated serum NFL levels seen in both pathologies. Future studies will determine whether NFL is a long COVID marker and delineate NFL's role in COVID-19-associated preeclampsia.

Keywords: COVID-19; SARS-CoV-2; hypertension; long COVID; neurofilament; preeclampsia; pregnancy; sNFL.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Published and suggested mechanisms of induction and secretion of sNFL that might be contributing to the elevated maternal levels of NFL seen in preeclampsia and COVID-19 Cellular origin of neurofilament during neurogenesis and placental development and mechanistic similarities among the two pathologies are highlighted, indicating physiological sources of sNFL and ectopic expression and release. CSF, cerebrospinal fluid; BBB, blood-brain barrier; MSC, mesenchymal stem cell; HIF-1, hypoxia-inducible factor 1, NEUROD1, neurogenic differentiation 1; hCG, human chorionic gonadotropin; UC, umbilical cord.
Figure 2
Figure 2
A summary of the known NFL release and suggested NFL ectopic expression mechanisms in COVID-19 and preeclampsia

References

    1. The Lancet Neurology Long COVID: understanding the neurological effects. Lancet Neurol. 2021;20:247. - PMC - PubMed
    1. Paterson R.W., Benjamin L.A., Mehta P.R., Brown R.L., Athauda D., Ashton N.J., Leckey C.A., Ziff O.J., Heaney J., Heslegrave A.J., et al. UCLH Queen Square COVID-19 Biomarker Study Group Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes. Brain Commun. 2021;3:b099. - PMC - PubMed
    1. Frederiksen K., McKay R.D. Proliferation and differentiation of rat neuroepithelial precursor cells in vivo. J. Neurosci. 1988;8:1144–1151. - PMC - PubMed
    1. Garcia M.A., Barreras P.V., Lewis A., Pinilla G., Sokoll L.J., Kickler T., Mostafa H., Caturegli M., Moghekar A., Fitzgerald K.C., Pardo C.A., Hopkins Neuro-COVID-19 Group Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm. J. Neurol. Sci. 2021;427:117517. - PMC - PubMed
    1. Prudencio M., Erben Y., Marquez C.P., Jansen-West K.R., Franco-Mesa C., Heckman M.G., White L.J., Dunmore J.A., Cook C.N., Lilley M.T., et al. Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19. Sci. Transl. Med. 2021;13:eabi7643. - PMC - PubMed